Rare diseases
Investigational molecules
Locations
Back to Spain132 clinical trials in Jaen, Spain across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)Study of Zenagamtide (NNC0487-0111) versus placebo in patients with heart failure with preserved or mildly reduced ejection fraction and obesity
SpainA study of PF-08634404 and sigvotatug vedotin in patients with advanced solid tumors
SpainA study of PF-08634404 and a drug combination for adult patients with extensive-stage small cell lung cancer
SpainA study of YL201 and atezolizumab for patients with advanced solid tumors
SpainStandardization of Olea europaea pollen extract for patients with olive pollen allergies
SpainStudy of ziftomenib with drug combinations for adults with newly diagnosed acute myeloid leukemia with NPM1 or KMT2A genetic changes
SpainA study comparing venetoclax, azacitidine, and quizartinib versus venetoclax and azacitidine in newly diagnosed acute myeloid leukemia patients not suitable for standard chemotherapy
SpainA Study of Evorpacept Combined with Trastuzumab and Chemotherapy for Patients with Metastatic HER2-Positive Breast Cancer
SpainStudy of ribociclib with or without chemotherapy for patients with hormone receptor positive, HER2 negative early breast cancer at intermediate risk
SpainA Study Comparing RLY-2608 and Fulvestrant with Capivasertib and Fulvestrant for Patients with PIK3CA-Mutant Hormone Receptor Positive, HER2-Negative Advanced Breast Cancer
SpainA study comparing BNT323 with chemotherapy in patients with HER2-expressing recurrent endometrial cancer who received previous treatment
SpainStudy of PF-07248144 and fulvestrant in adults with hormone receptor-positive, HER2-negative advanced or metastatic breast cancer who had progression after CDK4/6 inhibitor therapy
SpainThe busiest research cities in the country
What the registry says about research in the country
Multiple studies focusing on non-small cell lung cancer and small cell lung cancer treatments, investigating novel combination therapies and targeted approaches for different disease stages.
Research emphasizes improving survival rates through innovative therapeutic approaches for both extensive and limited-stage disease.
Comprehensive research into HER2-positive and hormone receptor-positive breast cancer, exploring new treatment combinations and targeted therapies.
Studies focus on both early-stage and metastatic disease, with emphasis on personalized treatment approaches.
Diverse research covering hepatocellular carcinoma, bladder cancer, and other solid tumors, evaluating novel therapeutic strategies.
Investigations aim to improve treatment outcomes across multiple cancer types using cutting-edge therapeutic approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
